ArticleiScience2026
Comprehensive assessment of alternative splicing analysis methods for single-cell RNA-seq.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alternative splicing expands transcriptomic and proteomic diversity and contributes to cell identity and function. Advances in single-cell RNA sequencing enable transcriptome profiling at cellular resolution, yet their performance across biologically relevant tasks has not been systematically evaluated. Here, we benchmark six representative alternative splicing analysis methods across multiple full-length, short-read scRNA-seq datasets, focusing on biologically relevant tasks including cell clustering and differential splicing detection. Among these methods, scQuint achieves robust performance across datasets and tasks. Application of scQuint to stem cell differentiation and tumor-associated immune cell datasets identifies cell type-specific splicing programs with biological significance. These results provide guidance for method selection and highlight the value of single-cell splicing analysis for uncovering regulatory mechanisms beyond gene expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.